PDCD1LG2 and pancreatic neoplasm: Additionally, Davidson et al. using CRISPR, shRNA, and flow cytometry in mouse models, showed that the immune checkpoint PD-L2 (PDCD1LG2) is predominantly found in the stroma of pancreatic cancer.